ABBV Featured as Dividend ETF Holding in HDV vs. FDVV Comparison
What happened
AbbVie (ABBV) appears as a constituent holding in an analysis comparing two high-dividend ETFs — iShares HDV and Fidelity FDVV — published by The Motley Fool on July 4, 2026. The piece examines yield, expense ratios, and sector weightings across both funds. AbbVie's inclusion reflects its ongoing status as a high-yield large-cap within dividend-focused passive strategies. Shares closed at $261.07 with no price movement recorded on the Independence Day holiday session.
The QL Read
U.S. markets were closed July 4, leaving breadth data at 0 advancing/0 declining. Against that quiet tape, ABBV's QuantLogix composite score reads 65/100, consistent with its profile as a high-yield large-cap holding heading into the next active session.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.